References
- HughesB. 2007 Hughes FDA drug approvals: a year of flux. Nat. Rev. Drug Discov.8, 107–109 (2009).
- PAREXEL’s Bio/Pharmaceutical R&D Statistical Sourcebook 2008/2009.
- Garnier JP. Rebuilding the R&D engine in big pharma. Harv. Bus. Revi.86(5), 68–70, 72–76, 128 (2008).
- Miller HI, Henderson DR. Governmental influences on drug development: striking a better balance. Nat. Rev. Drug Discov.6(7), 532–539 (2007).
- Sánchez-Serrano I. Success in translational research: lessons from the development of bortezomib. Nat. Rev. Drug Discov.5(2), 107–114 (2006).
- Hughes B. Novel consortium to address shortfall in innovative medicines for psychiatric disorders. Nat. Rev. Drug Discov.8(7), 523–524(2009).
- Harnessing open innovation. Nat. Rev. Drug Discov.8(5), 344–345 (2009).
- International Expert Group on Biotechnology. Innovation and Intellectual Property. McGill, Montreal, Canada (2008).
- Pharma Futurology. Joined-up Healthcare 2016 and Beyond. British Telecommunications plc., London, UK (2007).
- Open Innovation – Researching a New Paradigm. Chesbrough C, Vanhaverbecke W, West J (Eds), Oxford University Press, Oxford, UK (2006).
Websites
- ISDB Declaration on therapeutic advance in the use of medicines 2001. www.isdbweb.org
- NIHR Health Technology Assessment programme. www.ncchta.org
- European Network for Health Technology Assessment. www.eunethta.net/Work_Packages
- Microsoft’s Health Vaul. http://healthvault.com
- Google Health. www.google.com/health
- Procter & Gamble’s Connect & Develop. www.pgconnectdevelop.com
- InnoCentive. www.innocentive.com
- High Tech Campus. www.hightechcampus.nl
- The Pfizer Incubator. www.thepfizerincubator.com
- Lilly’s Phenotypic Drug Discovery Initiative. https://pd2.lilly.com/pd2Web/
- British NICE. www.nice.org.uk